References
Leone G, Mele L, Pulsoni A, Equitani F, Pagano L . The incidence of secondary leukemias. Haematologica 1999; 84: 937–945.
Leung W, Ribeiro RC, Hudson M Hudson M, Tong X, Srivastava DK, Rubnitz JE et al. Second malignancy after treatment of childhood acute myeloid leukemia. Leukemia 2001; 15: 41–45.
de Nully Brown P, Hoffmann T, Hansen OP Hansen OP, Boesen AM, Gronbaek K, Hippe E et al. Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML. Leukemia 1997; 11: 37–41.
Zanetti R, Crosignani P, Rosso S In: Cancer in Italy: Incidence Data from Cancer Registries, Lega Italiana per la Lotta contro i Tumori. Associazione Italiana dei Registri Tumori, Vol II. Torino: Il Pensiero Scientifico eds, 1997.
Mann KK, Shao W, Miller Jr WH . The biology of acute promyelocytic leukemia. Curr Oncol Rep 2001; 3: 209–216.
Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–789.
Acknowledgements
This work was supported in part by a grant from Ministry of University and Technological Research (MURST) of Italy.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Pagano, L., Pulsoni, A., Tosti, M. et al. Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials. Leukemia 18, 651–653 (2004). https://doi.org/10.1038/sj.leu.2403276
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403276
- Springer Nature Limited